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Purpose:Although autologous blood procurement has become a standard ofcare in elective 
surgery, recent studies have questioned its cost-effectiveness. We therefore reviewed our 3- 
year experience with intraoperative ceU salvage in patients who underwent elective 
abdominal aortic anetuysm repair. 
Methods: A 3-year retrospective chart review of elective abdominal aortic aneurysm 
(infrarenal and suprarenal) repair was performed. Transthoracic repairs were excluded. 
Results: Estimated blood lost was 1748 + 1236 ml, or 35% of baseline blood volume 
(5012 + 689 ml). Overall, 164 (89%) received red blood cell (RBC) transfusions (3.5 + 2.0 
U/patient). The cost per patient for cell salvage was $315 + $97, representing 31% of aU 
RBC costs and 24% of total blood component costs. Mean salvage volume infused was 
578 + 600 tal; at a mean hematocrit level of 55.7% the RBC volume infused from salvage 
during surgery was 313 + 328 ml (representing 27% of total RBC volume lost during the 
hospital stay). This mean RBC volume salvaged represented the equivalent of 1.6 blood 
bank RBC units. The mean blood bank costs saved by using cell salvage was $248, or 79% 
of the $315 actually spent for salvage. We found no decrease in percentage of patients 
undergoing transfusion until salvage volumes that were infused exceeded 750 ml, or the 
equivalent of two blood bank units; all of these patients who benefitted had estimated 
blood lost >1000 ml. 
Conclusions" We conclude that use of intraoperative c ll salvage was most beneficial for 
patients who had estimated blood loss greater than or equal to 1000 ml and cell salvage 
volumes infused greater than or equal to 750 ml. Patients who are estimated to lose less 
than 1000 ml receive little benefit yet incur substantial costs from intraoperative c ll 
salvage. (J Vase Surg 1996;24:213-8.) 
Autologous blood procurement for many surgical 
procedures has becomc a standard of care. 1 Recent 
studies, however, havc emphasized the poor cost- 
effectiveness ofpreoperative autologous donation in 
patients undergoing elective orthopedic, coronary 
bypass, and radical prostatectomy procedures. 2 s For 
patients undergoing vascular surgery intraoperative 
blood salvage and reinfusion has become the standard 
for autologous blood procurement. 69Therefore wc 
have reviewcd our experience in the use of intraop- 
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erative autologous blood salvage in patients who 
underwent elective abdominal aortic aneurysm repair 
to determine the relative costs of this blood conser- 
vation strategy. 
METHODS 
A retrospective r view over a 3-year period was 
conducted. Patients who underwent ransthoracic 
abdominal aneurysm repairs were excluded. One 
hundred eighty-four consecutive patients were iden- 
tified, of whom 19 underwent infrarenal and 165 
suprarenal repairs. Patient baseline blood volumes 
wcre dcrived from a nomogram based on patient sex, 
height, and weight.10 Estimated blood lost (EBL) for 
each patient during the surgical admission was calcu- 
lated by the differences between admission and dis- 
charge (last recorded) hematocrit multiplied by pa- 
täent whole blood volume 1° to determine the in vivo 
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Table I. Blood unit costs (dollar/unit) 
Red cells 
Autologous Allogeneic Plasma Hatelets 
Acquisition 104 93 40 40 
Lab 13 13 5 3 
Administration* 13 13 6 2 
Overhead t 39 36 15 14 
Total 169 155 66 59 
*Thirty-minute ime for registered nurse at $26.24/hr Assumption: Plasma nd platelets given in aliquots oftwo and six units, respectively, 
over a 30-minute per±od. 
{Thirty percent of costs. 
Table II. Clinical characteristics 
Female sex (%) 40 (22) 
Coronary arter disease (%) 77 (42) 
Previous coronary bypass (%) 26 (14) 
Hypertension (%) 92 (50) 
ASA classification (%) 
II 1 
III (%) 121 (64) 
IV (%) 62 (32) 
Age (yr) 69 _+ 7.0* 
Blood volume (ml) 5012 _+ 689* 
Red blood cell volume (ml) 1966 _+ 421" 
ASA, American Society of Anesthesiology. 
*Mean _+ SD. 
change in erythrocyte volume. Total RBC lost was 
then determined by the sum ofRBC volume lost plus 
the RBC volume (200 ml per RBC unit) transfused, n 
We also prospectively audited 100 consecutive 
patients in whom the cell saver was used to estimate 
the RBC mass ofsalvaged and washed blood that was 
infused. We found the mean hematocrit level of 
reinfused blood to be 55.7% (n = 100). Student's 
t test and Z 2 analysis were used to detect significant 
differences. 
Blood component costs were calculated as the 
sum acquisition costs (purchase price from the re- 
gional blood center, laboratory costs (inventory, 
blood type, and cross match), administration costs 
(supervision of transfusion), and overhead (30% of 
costs) and are summarized inTable I. Costs of red cell 
salvage were calculated for ( 1 ) equipment s andby was 
$178, the sum of labor was $90, software was $55, 
and equipment (Haemonetics ell-saver, Haemonetic 
Corp, Braintree, Mass) depreciation was $33, and (2) 
for salvage and reinfusion total costs equaled $363, 
the sum of labor was $175, software was $155, and 
equipment depreciation was $33. Cell salvage was 
ordered on a stand-by basis (i.e., equipment was set 
up in the room and available for immediate cell sal- 
vage and rein fusion at the discretion of the surgical 
te am). 
RESULTS 
The clinical charactcristics of 184 consecutive 
patients who underwent elective abdominal aortic 
aneurysm (AAA) repäir are detailed in Table II. Forty 
(22%) patients were female. Ninety-two (50%) and 77 
(42%) had a history of hypertension and coronary 
artery disease, respectively, and 26 (14%) had previ- 
ously undergone coronary bypass urgery. The mean 
(±SD) age was 69 _+ 7 years, ranging from 51 to 90 
years. One hundred twenty-one (66%) and 62 (34%) 
were American Society ofAnesthesiology class III and 
IV, respectively. Calcuhted patient whole blood vol- 
umes and red blood cell volumes on admission were 
5012 ± 689 ml and 1966 + 421 tal, respectively. 
The hospital course of the patients is summarized 
in Table III. Although the patients who tmderwent 
suprarenal repair had significantly longer anesthesia 
and operating room times, the surgical and hospital 
courses of the two groups were not different 
(Table III). The remaining analyses therefore were 
performed on the total patient group. For all patients 
EBL was 1748 _+ 1236 tal, which represented 35% of 
the patient basel±ne blood volume on admission. The 
mean cell saver volume salvaged and reinfused was 
578 _+ 600 tal; at a mean hematocrit of 55.7%, this 
represented a mean RBC volume salvaged and rein- 
fused during surgery of 313 + 328 ml. This repre- 
sented 18% of the total RBC volume calculated to 
have been lost during the nt±re hospitalization. The 
mean (median) duration of stay in intensive care and 
in the hospital was 7.8 (5) and 15.5 (12) days, respec- 
tively. Admission and discharge (last recorded) hema- 
tocrit levels were 40.2% ± 4.7% and 32.1% -+ 3.3%, re- 
spectively. Nadir (lowest recorded) hematocrit levels 
during and after surgery were 29.9 + 5.2 and 
31.7 + 5.2, respectively. The mean calculated RBC 
volume lost during the ent±re hospitalization was 
1186 _+ 704, which represented 60% of the basel±ne 
RBC volume. 
We found no difference in mean number of RBC 
JOURNAL O1 a VASCULAR SURGERY 
Volume 24, Number 2 Goodnough et al. 215 
Table III. Hospital course 
Infrarenal (n = 165) Suprarenal (n = 19) p All patients (n = 184) 
During surgery 
Operative time (min) 202 + 72 246 + 78 0.01 207 + 74 
Anesthesia time (min) 309 -+ 80 374 + 89 0.001 316 + 83 
Estimated blood lost (tal) 1723 + 1223 1968 + 1361 0.41 1748 + 1236 
C¢11 saver infused (tal) 
Whole blood 565 _+ 593 701 +_ 665 0.35 578 + 600 
Red btood cells (RBC) 304 + 322 390 _+ 371 0.28 313 + 328 
During hospital stay 
Hematocrit (%) 
Admission 40.2 + 4.8 40.8 + 4.4 0.62 40.2 + 4.7 
Nadir (surgery) 30.0 + 5.1 29.5 + 6.1 0.72 29.9 + 5.2 
Nadir (after surgery) 31.7 + 5.4 3.2ö + 3.3 0.62 31.7 + 5.2 
Discharge 32.1 + 3.3 - 31.7 + 3.2 0.59 32.1 + 3.3 
Days in intensive care 7.9 +_ 9.0 6.8 + 4.0 0.61 7.8 + 8.6 
Days in hospital 15.7 + 11.5 14.3 + 8.0 0.60 15.5 +- 11.2 
Calculated RBC lost 
During hospitalization 1158 + 677 1425 + 899 0.13 1186 + 704 
Table IV. Relation between cell saver volume (ml) salvaged and blood units transfused 
Blood units tran~fused 
Patients transfused 
Cell salvage (tal) 0 1 2 3 4 5 >6 Units tranqVused (%) 
0 4 3 4 4 6 3 12 5.1 + 3.7 89 
<250 1 0 5 2 1 3 1 3.5 + 1.5 92 
250-499 3 3 14 6 8 1 5 3.9 + 3.6 92 
500-749 4 3 10 4 3 3 9 4.1 + 4.2 89 
750-999 8 3 1 0 3 3 6 3.7 _+ 3.8 67 
_>1000 5 3 1 4 3 7 12 6.1 + 4.3 86 
Total patients (n) 25 15 35 20 24 20 45 87 
units transfused between i frarenal (3.5 + 2.0 U) and 
suprarenal (3.6 + 2.3 U) repairs; patients undergoing 
suprarenal repairs did receive, on average, more 
plasma (1.8 + 2.5 U vs 0.7 + 1.9 U) and platelet 
(1.5 + 2.2 vs 0.7 + 1.9 U, respectively) than patients 
undergoing infrarenal repairs. Overall, 163 (89%) of 
184 patients received blood products; all but two of 
these received RBCs. In addition, 37 (20%) received 
plasma, 36 (20%) received platelets, and two (not 
shown) received atotal of 4 U cryoprecipitate. Four- 
teen (8%) and 36 (20%) ofpätients received only one 
or two RBC units, respectively. The chronologic 
makeup of red cell transfusions was also analyzed. 
Only 12 (6%) of patients underwent transfusion 
before surgery. One hundred twenty-eight (70%) 
received RBC during surgery, and 77 (42%) received 
RBC after Surgery on the day of surgery. Fifty-six 
(30%) and 63 (34%) patients underwent transfusion 
with RBCs on postoperative days 1 and 2, respec- 
tively. 
The relation between cell saver volume processed 
and reinfused and the number of RBC units trans- 
fused is detailed in Table IV. Thirty-two (89%) of 36 
patients who had no cell salvage reinfusion received 
RBCs. This was not different from the percentage of
patients who underwent transfusion with RBCs and 
had ccll salvagc rcinfusion, except for ]6 (67%) of 24 
paticnts (p < 0.05 )who had 750 to 999 ml processed. 
The relation between EBL and cell saver volume 
salvaged isdetailed in Table V. Thirty-one (63%) of 49 
paticnts with EBL less than 1000 ml had cell salvage 
performed compared with 120 (88%) of 138 patients 
who had greater than or cqual to 1000 ml EBL 
(p < 0.05). Again, we found no differences in likcli- 
hood of allogeneic transfusion when patients were 
stratified according to EBL or cell salvagc volume. 
Finally, the relation between EBL and RBC units 
transfused is examined inTable VI. The percentage of
patients who had EBL greater than or equal to 1000 
and who received RBCs was not different from the 
percentagc of patients who had EBL lcss than 1000 
and who received RBCs (117 [85%] of 138 vs 44 
[89%] of 49, rcspectively, p = 0.26). 
The costs of blood conservation a d blood trans- 
fusion per proccdure are shown in Table VII. The cost 
of cell salvage was $326 __ $73 per procedure, repre- 
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Table V. Relation between estimated blood lost, cell saver volume salvaged, and red cell transfusions 
in 184 paticnts 
Estimated operative blood lost (tal) 
Cell salvage (tal) <250 250-499 500-749 750-999 >_1000 Total patients Percent ransfused 
0 0 2 11 5 18 36 89 
<250 1 1 4 0 7 13 92 
250-499 0 0 12 4 24 40 92 
500-749 0 0 0 1 35 36 89 
750-999 0 1 0 0 23 24 67 
>-1000 0 0 4 2 29 35 86 
Totalpatients 1 4 31 12 136 184 
Table VI. Relation between estimated blood lost and blood units transfused in 184 patients 
Blood units transfused 
EBL 0 1 2 3 4 5 >_6 Total patients Percent ransfused 
<250 0 0 1 0 0 0 0 1 100 
250-499 0 1 1 1 0 0 i 4 100 
500-749 4 1 9 4 7 2 4 31 87 
750-999 0 2 2 2 2 i 3 12 100 
>-1000 21 11 22 13 15 17 37 136 85 
TotN 25 I5 35 20 24 20 45 184 87 
senting 24% of the total blood product costs. Because 
the mean RBC volume salvaged of 304 ml was 
equivalent to 1.6 _+ 1.7 blood bank units (at 200 
ml/RBC unitll), the blood bank costs "saved" with 
cell salvaged could be calculated as $248 ___ $262, and 
the net costs ofcell salvage could be determined tobe 
$84 _+ $229. Nevertheless, in only 40 (22%) of the 
procedures did cell salvage actually reduce total costs, 
whereas the costs ofcell salvage xceeded the savings 
in the remaining 147 (78%) patients. 
DISCUSSION 
Patients undergoing elective AAA repair require 
substantial transfusion support. This has led to the 
widespread use of intraoperative c ll salvage. Meth- 
odologic improvements have eliminated eleterious 
effects formerly attributed to this technique) 20ur  
results confirm that cell salvage is valuable in patients 
undergoing AAA repair. However, we found that on 
average the equivalent of only 1.6 blood bank units 
were salvaged. We were able to identify that 53 (38%) 
of the 138 patients who had EBL that exceeded 1000 
ml (a threshold representing only 20% of the mean 
patient baseline whole blood volume) benefitted from 
cell salvage with reduced likelihood of blood transfu- 
sion. For 40 (29%) of these patients the cell saver 
technique was also associated with substan6al cost 
savings. 
Previous tudies have reported significant blood 
conservation with this technique inAAA procedures; 
one center eported that the amount of allogeneic 
blood decreased from 5.9 to 1.7 U per patient. 6 A 
later eport from the same center found that use ofcell 
salvage in 72 patients was associated with a mean of 
1.9 allogeneic blood unit transfusions; 26 (36%) of 
these avoided allogeneic blood transfusions entircly.13 
They compared these results with those of a study 
group of 73 patients undergoing AAA repair who, in 
addition to use of cell salvage, predonated a meän of 
1.9 autologous blood units before surgery. The use of 
both techniques in this group was associated with a 
mean of 1.3 allogeneic blood units (not different); 
however, 49 (67%) of these patients avoided alloge- 
neic blood transfusions. Although the use of com- 
bined blood conservation strategies has appeal, recent 
analyses of  autologous blood predonation 2-shave 
demonstrated that he use ofeven this single approach 
is poorly cost-effective, in large part because of 
substantial improvements in the safety of the blood 
supply. 14 Similarly, a previous analysis of the value of 
cell salvage in patients undergoing elective orthopedic 
surgery concluded that this technique was of no 
benefit for lmee replacement surgery and that the 
procedure was cost-neutral for hip replacement and 
spine fusion procedures only when the equivalent of 
three bank blood units were salvaged, is Finally, an- 
other smdy of cell salvage in patients undergoing 
orthopedic, coronary bypass, or AAA procedures 
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Table Vl I .  Blood conservation and blood transfusion costs ($) 
Mean + SD Range 
Blood transfusion 
RBC 705 + 606 0 to 3410 
Plasma 84 + 236 0 to 1782 
Platelets i95 + 527 0 to 3540 
Total 985 + 1086 117 to 6103 
Blood conservafion 
Cost spent on salvage 326 _+ 73 117 to 362 
Cost saved with cell salvage 242 _+ 254 0 to 1619 
Ner cost ofcell salvage 84 + 229 -1257 to 297 
found that use of the cell saver in the orthopedic and 
coronary bypass procedures was not cost-equivalent; 
in patients who underwcnt AAA repair, however, 56% 
of the procedures were cost-equivalent. 16 
It is noteworthy that the RBC transfusion require- 
ments (3.5_ 2.0 per patient) in our study wcre 
substantial evcn with the use of the cell saver. This is 
in part due to the significant red cell losses associated 
with AAA repair; we found that overall the calculated 
RBC losscs (1158 _ 677 ml) during the entire hospi- 
talization represented 60% of the baseline RBC vol- 
urne (1966 -+ 421 ml) at admission. The transfusion 
practices for this patient group at our institution 
reflect he fact that these are pätients at risk, with a 
mean age of 69.3 years and a high prevalence of 
atherosclcrotic coronary artery disease. The nadir 
mean hematocrit levels during and after surgery were 
29.8% and 31.6%, respectively, and the mean dis- 
charge hematocrit lcvel was 32% (range 24.5% to 
41.9%). This is similar to the discharge hematocrit 
level of 33.4% (fange 25.2% to 41.3%) reported bythe 
Clevcland Clinic. 13 The broad range of hematocrit 
levels at both centers uggest that the most effective 
approach to reduction of allogencic blood use may be 
to standardize red cell transfusion practices among 
anesthesiologists and surgeons for a single institu- 
tion. 17 At the same time a morc physiologie indicator 
for the necd for transfusion than the hematocrit levcl 
may also improve transfusion outcomes, la 
CONCLUSION 
Wc found that use of intraoperafive cell salvage 
was cost-neutral for nly 40 (22%) ofpatients under- 
going AAA repair. The patients for whom cell salvage 
was most beneficial were those who had EBL greater 
than or equal to 1000 ml and cell salvage volumes 
infused greater than or equal to 750 ml. Patients who 
have EBL less than 1000 ml receive little benefit yet 
incur substantiäl costs from intraoperative cell sal- 
vage. We conclude that although routine s tup of the 
cell saver is indicated for these patients, he actual cell 
salvagc should be performed only for those patients 
with more than 1000 ml blood loss in the canister. 
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